Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CTF MEG is a Canadian neurotechnology and medical device company focused on magnetoencephalography systems for measuring human brain function. The business sells and services commercial MEG systems, including the CTF 275 platform, along with related installation, training, maintenance, refurbished systems, and support offerings. Its technology is used by hospitals and research institutions for presurgical epilepsy evaluation, functional mapping, and broader neuroscience research. The company traces its technology roots to early SQUID-based sensing work and has continued to support both CTF and legacy 4D Neuroimaging customers. Although it operates in healthcare, it is not a therapeutics developer and does not appear to have a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CTF MEG International Services.